New Systemic Inflammatory Indices as Predictors of Fulminant Myocarditis in Children

Demet Kangel1, İsa Ozyılmaz1, Sercin Ozkok2

  • 1Division of Pediatric Cardiology, Department of Pediatrics, Basaksehir Cam and Sakura City Hospital, Istanbul 34480, Turkey.

Insights

New systemic inflammatory indices, Systemic Immune-Inflammation Index (SII) and Systemic Inflammatory Response Index (SIRI), can predict adverse outcomes in pediatric myocarditis. These simple blood markers offer early prognostic insights for children with myocarditis.

Area of Science:

  • Pediatric Cardiology
  • Inflammatory Diseases
  • Biomarker Discovery

Background:

  • Myocarditis is a significant cause of pediatric morbidity and mortality, potentially leading to severe long-term cardiac complications.
  • New systemic inflammatory indices combining lymphocyte, neutrophil, and platelet counts show promise as prognostic markers.

Purpose of the Study:

  • To investigate the utility of novel systemic inflammatory indices as early predictive markers for adverse outcomes in pediatric myocarditis.
  • To compare these indices between fulminant and non-fulminant pediatric myocarditis cases.

Main Methods:

  • Retrospective analysis of 122 pediatric myocarditis patients (age >1 month to <18 years) diagnosed between January 2022 and December 2024.
  • Classification of patients into fulminant (requiring hemodynamic support) and non-fulminant groups.
  • Calculation and comparison of Systemic Immune-Inflammation Index (SII) and Systemic Inflammatory Response Index (SIRI) values within the first 6 hours of diagnosis.

Main Results:

  • The study included 122 pediatric myocarditis cases; 21.3% developed fulminant myocarditis.
  • Median SII was significantly higher in the fulminant group (1300) compared to the non-fulminant group (500) (p < 0.05).
  • Median SIRI was also significantly higher in the fulminant group (2.9) versus the non-fulminant group (1.5) (p < 0.05). Cut-off values for SII and SIRI were established for predicting fulminant myocarditis.

Conclusions:

  • The Systemic Immune-Inflammation Index (SII) and Systemic Inflammatory Response Index (SIRI) show potential as independent predictors of adverse myocarditis prognosis in children.
  • These indices are easily calculable from routine blood tests, offering a practical approach for early risk stratification in pediatric myocarditis.